UCSF Health Orthopedic Surgery, St. Mary's

MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.

Patients will fill out PRO's after surgery

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (C...

The primary objective of this access and distribution protocol is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.

Recruiting

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Gl...

Tolerability is defined as the proportion of participants receiving at least one dose of DB107-RRV and DB107-FC with a reported dose-limiting toxicity for all participants in Phase I.

Recruiting

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

Rate of dose limiting toxicities (DLT)

Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic S...

Number of subjects with a dose limiting toxicity (DLT)

Recruiting

Autologous Gene Therapy for Artemis-Deficient SCID

Patient survival status and (if applicable) cause of death will be recorded to assess overall survival.

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpr...

Create a large scale registry of full genome expression data with clinical data to investigate possible new gene associations with prognostic or predictive value.

Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Participants will be assessed for lung injury at 24 months after HSCT

Recruiting

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

The average change in functional ability as measured by the American Shoulder and Elbow Surgeons (ASES) score. ASES is an absolute score ranging from 0 to 100 where a higher score indicates better shoulder function.

Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Safety will be measured by those events in the European Safety Surveillance (EUHASS). 1. Allergic or other acute events 2. Treatment-emergent side effects of therapy 3. Transfusion transmitted infections 4. Inhibitor d...

Recruiting